Dr Anubhab Mukherjee
Dr Anubhab Mukherjee
Principal Scientist, R&D, Esperer Onco Nutrition (EON) Pvt Ltd
Verified email at esperernutrition.com
Title
Cited by
Cited by
Year
Lipid–polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives
A Mukherjee, AK Waters, P Kalyan, AS Achrol, S Kesari, VM Yenugonda
International journal of nanomedicine 14, 1937, 2019
812019
Recent trends of the bio-inspired nanoparticles in cancer theranostics
VS Madamsetty, A Mukherjee, S Mukherjee
Frontiers in pharmacology 10, 1264, 2019
362019
Recent progress in the theranostics application of nanomedicine in lung cancer
A Mukherjee, M Paul, S Mukherjee
Cancers 11 (5), 597, 2019
352019
Designing Stimuli‐Responsive Upconversion Nanoparticles that Exploit the Tumor Microenvironment
M Ovais, S Mukherjee, A Pramanik, D Das, A Mukherjee, A Raza, C Chen
Advanced Materials 32 (22), 2000055, 2020
202020
Recent advancements of nanomedicine towards antiangiogenic therapy in cancer
A Mukherjee, VS Madamsetty, MK Paul, S Mukherjee
International journal of molecular sciences 21 (2), 455, 2020
192020
Antibody drug conjugates: Progress, pitfalls, and promises
A Mukherjee, AK Waters, I Babic, E Nurmemmedov, MC Glassy, S Kesari, ...
Human antibodies 27 (1), 53-62, 2019
182019
Liposomally encapsulated CDC20 siRNA inhibits both solid melanoma tumor growth and spontaneous growth of intravenously injected melanoma cells on mouse lung
A Mukherjee, J Bhattacharyya, MV Sagar, A Chaudhuri
Drug delivery and translational research 3 (3), 224-234, 2013
152013
Recent advancements of nanomedicine in neurodegenerative disorders theranostics
S Mukherjee, VS Madamsetty, D Bhattacharya, S Roy Chowdhury, ...
Advanced Functional Materials 30 (35), 2003054, 2020
112020
Functionalization of Nanomaterials and Their Application in Melanoma Cancer Theranostics
VS Madamsetty, MK Paul, A Mukherjee, S Mukherjee
ACS Biomaterials Science & Engineering 6 (1), 167-181, 2019
22019
Supramolecular combinatorial therapeutics
M Roy, S Hossain, A Sengupta, S Mylavarapu, S Sengupta, A Mukherjee
US Patent 10,426,753, 2019
22019
Cellular signalling inhibitors, their formulations and methods thereof
M Roy, G Biswas, H Suryavanshi, A Mukherjee, A Kulkarni, S Sengupta
US Patent 10,736,968, 2020
12020
Emerging Trends in Immunomodulatory Nanomaterials Toward Cancer Therapy
A Mukherjee, VS Madamsetty, S Mukherjee
Synthesis Lectures on Biomedical Engineering 16 (1), i-84, 2021
2021
Advances in the Fabrication of Scaffold and 3D Printing of Biomimetic Bone Graft
B Bisht, A Hope, A Mukherjee, MK Paul
Annals of Biomedical Engineering, 1-23, 2021
2021
Biosynthesized Gold and Silver Nanoparticles in Cancer Theranostics
SK Nethi, A Mukherjee, S Mukherjee
Handbook of Nanomaterials and Nanocomposites for Energy and Environmental …, 2020
2020
Biosynthesized Gold and Silver Nanoparticles in Cancer Theranostics
NS Kumar, A Mukherjee, S Mukherjee
Handbook of Nanomaterials and Nanocomposites for Energy and Environmental …, 2020
2020
Method for inhibiting tumor growth through RNA-interference using liposomally associated CDC20 siRNA
A Mukherjee, J Bhattacharyya, A Chaudhuri
US Patent 10,227,589, 2019
2019
Method for inhibiting tumor growth through RNA-interference using liposomally associated CDC20 siRNA
A Mukherjee, J Bhattacharyya, A Chaudhuri
US Patent 10,227,589, 2019
2019
On the possible involvement of bovine serum albumin precursor in lipofection pathway
A Mukherjee, J Bhattacharyya, A Chaudhuri
Journal of biosciences 39 (1), 43-52, 2014
2014
Non-viral siRNA delivery in RNA interference: Accomplishments, set-backs and future promises
A Mukherjee, A Chaudhuri
JOURNAL OF THE INDIAN CHEMICAL SOCIETY 90 (10), 1861-1869, 2013
2013
Structure-Activity Studies on Cationic Lipid Mediated RNA-Interferance & Mechanistic Investigation of Plasmid DNA Nuclear Import in Lipofection
A Mukherjee
2013
The system can't perform the operation now. Try again later.
Articles 1–20